Purpose: The aim of this study was to review the epidemiology, clinical features, diagnosis, and effect of treatments of aspergillosis infections in adult liver transplantation patients. Methods: We retrospectively studied the cases of aspergillosis among 625 (164 deceased donor liver transplantation (DDLT), 461 living donor liver transplantation (LDLT)) adult liver transplantation recipients (≥18 yrs old) operated between May 1996 to May 2008. Results: Fourteen cases of aspergillosis infection were detected, which consisted of 9 cases of invasive aspergillosis, 5 cases of aspergilloma in maxillary sinuses which occurred before the transplantation. One patient with invasive aspergillosis, who had received liver transplantation overseas and had post-operation care in our center, was also included. Among the 8 cases (1.28%) of invasive aspergillosis (excluding one case operated overseas), 6 cases (3.7%) were DDLT and 2 cases (0.4%) LDLT (P-value＜0.05). Among the 6 patients with early onset of invasive aspergillosis, 5 patients (1.8%) had fluconazole and only 1 patient (0.3%) had itraconazole as prophylactic antifungal agent (P-value＜0.05). The three cases with localized lesions in the lung survived after lobectomy, but the disseminated and inoperable cases died.
INTRODUCTION
Invasive aspergillosis is an uncommon infection, but is a serious and devastating complication after liver transplantation (LT). The incidence of invasive aspergillosis varies depending on the organ transplant involved are liver (1∼8%), kidney (0∼4%), lung (3∼14%) and heart (1∼ 
2) Method
Urine, sputum, drains, bile, wounds, and blood in all recipients after LT were examined routinely twice a week as surveillance for infection. Invasive aspergillosis was defined as per criteria for proven or probable invasive Five cases had asymptomatic fungus ball in maxillary sinus which was detected before LT by ostiomeatal unit 
